TORONTO, Nov. 11, 2021 /CNW/ - HLS Therapeutics Inc.
("HLS" or the "Company") (TSX: HLS), a pharmaceutical company
focused on central nervous system and cardiovascular markets,
announces that Gilbert Godin, Chief
Executive Officer, and Tim
Hendrickson, Chief Financial Officer, will present at the
Stifel 2021 Virtual Healthcare Conference on Tuesday November 16, 2021 at 8:40 a.m. Eastern Standard Time. The conference
will be held in a virtual meeting format.
An audio webcast of the Company's presentation will be available
at: https://wsw.com/webcast/stifel58/hls.to/2371680
To register for the conference and schedule a one-on-one meeting
with HLS, please contact your Stifel representative.
ABOUT HLS THERAPEUTICS INC.
Formed in 2015, HLS is a pharmaceutical company focused on the
acquisition and commercialization of late-stage development,
commercial stage promoted and established branded pharmaceutical
products in the North American markets. HLS's focus is on products
targeting the central nervous system and cardiovascular therapeutic
areas. HLS's management team is composed of seasoned pharmaceutical
executives with a strong track record of success in these
therapeutic areas and at managing products in each of these
lifecycle stages. For more information, please visit:
www.hlstherapeutics.com
SOURCE HLS Therapeutics Inc.